Survey Reveals Women May Be Experiencing Perimenopause in Their 40s
By Lori Solomon HealthDay Reporter
FRIDAY, April 25, 2025 -- Six in 10 women believe they will hit menopause in their 40s, according to survey results released April 8 by The Ohio State University Wexner Medical Center in Columbus.
The survey (web and telephone) was conducted in two waves from Feb. 7 to 10, 2025, and Feb. 21 to 24, 2025, with responses from a combined total of 1,068 female respondents.
According to the results of the survey, 61 percent believe they will hit menopause in their 40s. Half of the women surveyed (52 percent) believed diet and exercise can help treat menopause symptoms. One in three women were concerned about the long-term health effects of menopause. Other concerns included physical symptoms (25 percent) and mental health (18 percent). Younger women were more likely to have a top concern of mental health related to menopause compared with older women (25 percent of those aged 18 to 29 years versus 10 percent of those aged 65 years and older).
“Perimenopause is when the menstrual cycle has started to change, and it is persistent. The formal definition is periods fluctuate by at least seven days for at least 10 months,” Lauren Baker, D.O., of The Ohio State University Wexner Medical Center, said in a statement. "Problems in the workplace, adverse effects on one's quality of life, and adverse health events all have been associated with menopause, too. There are effective treatments and ways to feel better to not only survive but thrive."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-26 06:00
Read more

- Most Women Aren't Clear When Menopause Might Start
- Common Photosensitizing Drugs Increase Skin Cancer Risk
- Most Eligible Smokers Not Getting Lung Cancer Screening
- Drug Overdose Deaths Rising Faster in Black Americans, Study Finds
- Lilly's Lepodisiran Reduced Levels of Genetically Inherited Heart Disease Risk Factor, Lipoprotein(a), by Nearly 94% from Baseline at the Highest Tested Dose in Adults with Elevated Levels
- Roux-en-Y Gastric Bypass, Sleeve Gastrectomy Beat Adjustable Gastric Banding for Severe Obesity
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions